Clarivate(CLVT)
icon
搜索文档
Clarivate Reveals Citation Laureates 2024
Prnewswire· 2024-09-19 15:00
文章核心观点 - 该文章介绍了2024年度Clarivate Citation Laureates获奖名单,这些科学家和经济学家在各自领域做出了开创性贡献,其工作被认为达到了诺贝尔奖水平 [1][2][3] - 这些Citation Laureates分布在6个国家,包括美国、英国、瑞士、德国、以色列和日本,他们在清洁能源、纳米技术、3D蛋白质结构、腐败经济影响、心脏病、分子动力学、量子计算、基因印记和凝聚态物理等领域做出了重大贡献 [2][4][5][6] - 这些科学家的研究论文被广泛引用,对社会产生了广泛影响,Clarivate公司表示这是对他们开创性工作的一种认可 [3] 行业总结 - 该奖项旨在预测未来可能获得诺贝尔奖的科学家,Clarivate公司自2002年开始通过Web of Science数据库识别这些潜在的诺贝尔奖获得者 [3] - 获奖者分布在医学生理学、物理学、化学和经济学等领域,他们在这些领域做出了开创性贡献,推动了相关领域的发展 [4][5][6] - 该奖项突出了这些科学家在推动科技创新和社会进步方面的重要作用,是对他们工作的高度认可 [3] 公司总结 - Clarivate公司是一家全球领先的转型情报提供商,通过旗下的Web of Science数据库,识别出了这些潜在的诺贝尔奖获得者 [3][7] - 公司表示,这些Citation Laureates的工作对社会产生了广泛影响,是对他们开创性工作的一种认可 [3] - Clarivate公司希望通过这个奖项,突出这些科学家在推动科技创新和社会进步方面的重要作用 [3]
Clarivate Announces 15th Annual Pharmavision India Conference Agenda
Prnewswire· 2024-09-18 15:00
Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences eventLONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 15th annual Clarivate Pharmavision India conference. The 15th edition of Pharmavision India reinforces the industry's dedication to patient welfare, highlighting how collective efforts and innovative strategies have transformed ...
Clarivate Launches Generative AI-Powered Primo Research Assistant
Prnewswire· 2024-09-18 15:00
Transforming library discovery with Academic AI that provides users a new and easy way to find trusted content LONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched Primo™ Research Assistant. Developed in collaboration with partners from the library community, the new generative AI-powered library discovery solution offers a seamless experience for students and researchers. It provides immediate answers to natural language ...
Clarivate Report Unveils the Transformative Role of Artificial Intelligence on Shaping the Future of the Library
Prnewswire· 2024-09-09 15:00
LONDON, Sept. 9, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched its first Pulse of the LibraryTM report. The report reveals that libraries are in the early days of Artificial Intelligence (AI) implementation. Librarians are considering applications of AI that support the library mission, particularly in enhancing content discovery and increasing efficiency for their teams. However, there are notable concerns, including a lack of AI ex ...
Clarivate Launches Generative AI-Powered Web of Science Research Assistant
Prnewswire· 2024-09-04 15:00
Developed in partnership with the research community to implement high-quality AI tools responsiblyLONDON, Sept. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Web of Science™ Research Assistant. The new generative AI-powered tool helps researchers find key papers faster, handle complex research tasks and visualize connections. The chat interface combined with the Web of Science knowledge graph allows researchers to get more ou ...
Clarivate Names Melanie Margolin as Chief Administrative and Legal Officer
Prnewswire· 2024-08-20 15:00
LONDON, Aug. 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, has appointed Melanie Margolin to the expanded role of Chief Administrative and Legal Officer. She joined the company as Executive Vice President and Chief Legal Officer in September 2023.Ms. Margolin successfully leverages her experience as a seasoned executive to advance key strategic programs at Clarivate. She has a proven track record of establishing strong controls for complex org ...
Clarivate: Attractive Upside Even With Conservative Assumptions
Seeking Alpha· 2024-08-09 14:33
pixdeluxe Investment action I recommended a buy rating for Clarivate Plc (NYSE:CLVT) when I wrote about it in May, as I expected organic growth to improve when the macro climate gets better, and I did not see any structural weakness in the business given the strong customer retention metric. Based on my current outlook and analysis, I recommend a buy rating. My key update to my thesis is that the organic growth recovery story remains intact, and the two largest segments have shown good improvements in this ...
Clarivate to Present at the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference on August 12
Prnewswire· 2024-08-07 20:15
文章核心观点 - 公司宣布首席财务官将在即将举行的Oppenheimer年度科技、互联网和通信会议上发表演讲 [1] - 公司是一家全球领先的转型情报提供商,提供丰富的数据、见解和分析、工作流解决方案以及专业服务 [2] 公司概况 - 公司在学术与政府、知识产权以及生命科学与医疗保健领域提供服务 [2] 会议信息 - 公司首席财务官将于2024年8月12日下午2:55在Oppenheimer年度科技、互联网和通信虚拟会议上发表演讲 [1] - 演讲将通过网络直播的方式进行,并将提供回放 [1]
Clarivate to Present at the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference on August 12
Prnewswire· 2024-08-07 20:15
LONDON, Aug. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference, on Monday, August 12, 2024 at 2:55 pm Eastern Time. The live webcast can be accessed at https://wsw.com/webcast/oppenheimer37/clvt/2805750 and will be available for replay.A replay of each webca ...
Clarivate(CLVT) - 2024 Q2 - Earnings Call Transcript
2024-08-07 03:34
财务数据和关键指标变化 - 第二季度收入为6.5亿美元,同比下降1900万美元,上半年收入为12.7亿美元 [57][58] - 第二季度净亏损3.17亿美元,同比下降1.75亿美元,主要由于计提了生命科学与医疗保健分部的商誉减值 [59] - 第二季度调整后每股收益0.20美元,同比下降0.01美元,上半年为0.34美元,同比下降0.05美元,主要由于调整后EBITDA下降和折旧摊销费用增加 [60][61] - 第二季度经营活动现金流为1.26亿美元,同比下降3600万美元,上半年为3.02亿美元,同比下降8800万美元,主要由于营运资金时间性差异 [61][62] 各条业务线数据和关键指标变化 - 学术与政府分部订阅收入增长超过3%,续订率提高至96%以上 [30] - 学术与政府分部的非订阅收入受到一次性预算减少的影响有所下滑 [31] - 知识产权分部软件收入同比高个位数增长,获得了80%以上的大型竞争性软件交易 [39][40] - 知识产权分部专利情报产品Derwent续订率同比提高250个基点 [42] - 生命科学与医疗保健分部受到宏观环境影响,收入有所下降 [49] 各个市场数据和关键指标变化 - 学术与政府分部在国际市场和中型制药企业表现良好 [50] - 知识产权分部在日本市场获得大型交易,是关键市场 [40] 公司战略和发展方向及行业竞争 - 公司已重组为三大分部,加大创新和客户参与度投入 [19] - 公司正在推出多项新产品和解决方案,如Web of Science Research Intelligence、Collecto和Specto等 [34][35][36][42][44][51] - 公司正在整合自身的专利情报和实时数据,开发针对不同用户需求的新产品 [47][48][51][55] - 公司正在加强与客户的合作,通过新产品和解决方案提升客户价值 [32][35][36][40][50] 管理层对经营环境和未来前景的评论 - 公司已完成重组并奠定了良好基础,未来发展前景广阔 [13][25][26] - 新任CEO Matti Shem Tov将带领公司进入下一个增长阶段 [14][15][17][21] - 公司将继续投资创新,以加速未来几年的有机增长 [93][94] - 公司将采取更加均衡的资本配置策略,包括适当回购股票和进行有助于增长的并购 [92] 其他重要信息 - 公司原CEO Jonathan Gear将辞任,协助新任CEO Matti Shem Tov进行平稳过渡 [10][11][12][22][27] - 公司维持了2024年全年指引不变,预计全年收入和利润率接近中值 [73][74][75][76] - 公司预计第三季度有机增长将恢复至0%-1%,第四季度非订阅收入将有所改善 [74][80][81][82][83][84][85] 问答环节重要的提问和回答 问题1 **Toni Kaplan提问** 生命科学与医疗保健分部在当前环境下,大型项目的交付信心如何,是否存在被推迟至明年的风险 [99] **Jonathan Gear回答** 公司咨询业务表现良好,有较好的项目可见度,第四季度同比较弱也有利于改善,总体有信心完成 [100] 问题2 **Manav Patnaik提问** 新任CEO Matti的背景主要在学术与政府分部,对其他两个分部的发展有何影响 [103] **Jonathan Gear回答** Matti有丰富的执行力和业绩驱动经验,能够带领公司各个分部实现发展 [104][105] 问题3 **Surinder Thind提问** 公司是否更注重产品创新和缩短产品周期,2025年的新产品计划如何转化为增长 [107] **Jonathan Gear回答** 公司过去两年持续加大创新投入,新产品正逐步推出并带来收益,未来将继续推动创新驱动增长 [108][109]